Want to see IL:AURA full AI Analyst Report?
Top Page
Aura
(TASE:AURA)
Select Model
Select Model
Rating:60Neutral
Price Target:
1,670.00
▲(4.51% Upside)
Action:Reiterated
Date:09/06/26
The score is primarily held back by weak financial quality—persistent negative operating/free cash flow and elevated, rising leverage—despite solid revenue growth and healthy (but compressing) margins. Technicals are supportive with strong upward momentum, but overbought signals and a price still below the 200-day moving average temper the outlook. Valuation is moderate with a low dividend yield, providing limited cushion.
Positive Factors
Revenue growth and profitability
The combination of double-digit TTM revenue growth and still-healthy gross and net margins indicates the business is converting expansion into reported profitability. If maintained, this provides a durable base for reinvestment and supports operating resilience, although the trend should be monitored as the company scales.
Negative Factors
Rising leverage
The sharp increase in debt-to-equity and absolute debt reduces financial flexibility and makes results more sensitive to funding conditions. Elevated leverage can constrain future investment, increase financing costs, and amplify downside if operating performance or development outcomes weaken.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth and profitability
The combination of double-digit TTM revenue growth and still-healthy gross and net margins indicates the business is converting expansion into reported profitability. If maintained, this provides a durable base for reinvestment and supports operating resilience, although the trend should be monitored as the company scales.
Read all positive factors
Aura (AURA) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪4.52B
Dividend Yield1.21%
Average Volume (3M)411.80K
Price to Earnings (P/E)16.9
Beta (1Y)1.76
Revenue Growth47.76%
EPS Growth-2.38%
CountryIL
Employees223
SectorGeneral
Sector StrengthN/A
IndustryReal Estate - Development
Share Statistics
EPS (TTM)0.94
Shares Outstanding284,113,860
10 Day Avg. Volume390,868
30 Day Avg. Volume411,803
Financial Highlights & Ratios
PEG Ratio-0.88
Price to Book (P/B)3.58
Price to Sales (P/S)3.03
P/FCF Ratio-6.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aura Business Overview & Revenue Model
Company Description
Established in 1992 and based in Tel Aviv, Israel, Aura Investments Ltd. is an Israeli real estate firm dedicated to the conceptualization and execution of property developments. Its operations primarily involve the construction of new residential...
How the Company Makes Money
As a clinical-stage biotechnology company, Aura Biosciences has not publicly established recurring product revenue from commercialized therapies. Revenue, if any, is typically generated from non-commercial sources such as collaboration/licensing a...
Aura Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
54
Neutral
Cash Flow
28
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.24B | 1.90B | 1.52B | 1.04B | 849.01M | 893.89M |
| Gross Profit | 583.02M | 486.15M | 347.51M | 190.98M | 139.44M | 137.10M |
| EBITDA | 652.82M | 589.25M | 477.33M | 208.47M | 205.55M | 182.64M |
| Net Income | 269.89M | 280.75M | 360.14M | 117.69M | 140.54M | 113.53M |
Balance Sheet | ||||||
| Total Assets | 8.45B | 7.87B | 4.88B | 3.14B | 2.60B | 1.86B |
| Cash, Cash Equivalents and Short-Term Investments | 530.83M | 663.97M | 137.03M | 129.36M | 73.21M | 67.45M |
| Total Debt | 4.12B | 3.32B | 2.26B | 1.36B | 845.63M | 828.08M |
| Total Liabilities | 6.51B | 6.00B | 3.59B | 2.24B | 1.93B | 1.34B |
| Stockholders Equity | 1.67B | 1.61B | 1.27B | 882.03M | 652.64M | 520.38M |
Cash Flow | ||||||
| Free Cash Flow | -1.01B | -925.57M | -127.40M | -565.56M | 163.03M | 207.27M |
| Operating Cash Flow | -1.00B | -921.50M | -122.29M | -564.73M | 167.92M | 207.99M |
| Investing Cash Flow | 155.13M | 170.56M | -412.89M | -5.13M | -141.69M | -56.88M |
| Financing Cash Flow | 1.05B | 972.09M | 540.60M | 607.07M | -26.42M | -194.34M |
Aura Technical Analysis
Negative
1598.00
Price Trends
1652.43
Negative
1730.50
Negative
1951.10
Negative
Market Momentum
-32.28
Positive
37.61
Neutral
17.98
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AURA, the sentiment is Negative. The current price of 1598 is below the 20-day moving average (MA) of 1741.15, below the 50-day MA of 1652.43, and below the 200-day MA of 1951.10, indicating a bearish trend. The MACD of -32.28 indicates Positive momentum. The RSI at 37.61 is Neutral, neither overbought nor oversold. The STOCH value of 17.98 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:AURA.
Aura Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ₪2.78B | 5.42 | ― | 10.43% | 64.49% | 132.97% | |
64 Neutral | ₪6.93B | 6.23 | ― | 0.76% | 3.34% | 44.21% | |
63 Neutral | ₪2.57B | 8.96 | ― | ― | 37.38% | 35.54% | |
60 Neutral | ₪4.52B | 16.91 | ― | 1.21% | 47.76% | -2.38% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
44 Neutral | ₪1.06B | -6.21 | ― | 1.75% | 5.23% | 29.88% |
* General Sector Average
IL:AURA
Aura
1,590.00
-840.61
-34.58%
IL:SMT
Summit
4,018.00
-2,617.00
-39.44%
IL:AFPR
Afi Properties
16,560.00
-5,340.00
-24.38%
IL:ELCRE
Electra Real E.
1,540.00
-3,965.00
-72.03%
IL:BLSR
Blue Sq Real Es
29,650.00
-7,796.37
-20.82%
IL:ARGO
Argo Prop.
10,940.00
-300.00
-2.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.